Mirna Therapeutics, Inc., a biotechnology company pioneering microRNA
(miRNA) replacement therapies for cancer, announced today that it has
initiated a Phase 1 clinical study of MRX34, the first ... read more
Mirna Therapeutics, Inc., a biotechnology company pioneering microRNA
(miRNA) replacement therapies for cancer, announced that new preclinical
data from its lead product candidate will be presented this week ... read more